Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin S Daniel

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
JAAD International|August 19, 2021
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)Clare L Rogers, Matthew Gibson, Johannes S Kern, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2024
The development and validation of an investigator global assessment score for keratosis pilarisMadeline A Wang, Anna Wilson, Darby Boucher, et al.
JAMA Dermatology|August 9, 2013
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaireDeshan F Sebaratnam, Anna Marie Hanna, Shien-ning Chee, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.
Journal of the American Academy of Dermatology|November 8, 2011
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of expertsDedee F Murrell, Benjamin S Daniel, Pascal Joly, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of expertsDedee F Murrell, Branka Marinovic, Frederic Caux, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
JAAD International|August 19, 2021
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)Clare L Rogers, Matthew Gibson, Johannes S Kern, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2024
The development and validation of an investigator global assessment score for keratosis pilarisMadeline A Wang, Anna Wilson, Darby Boucher, et al.
JAMA Dermatology|August 9, 2013
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaireDeshan F Sebaratnam, Anna Marie Hanna, Shien-ning Chee, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.
Journal of the American Academy of Dermatology|November 8, 2011
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of expertsDedee F Murrell, Benjamin S Daniel, Pascal Joly, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of expertsDedee F Murrell, Branka Marinovic, Frederic Caux, et al.
Pageof 5